Zejula 100 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FCZDZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,535
Award facts
- Contract value 100% obligated
- $23,535.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of ZEJULA 100 mg tablets (30-count units) valued at $23,535.28 under a Firm Fixed Price contract. This delivery order represents a competitive, non-set-aside award to the prime contractor, with a performance location in Conshohocken, Pennsylvania, and an ultimate completion date of August 25, 2025. The award is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement running through December 2026 that enables pharmaceutical and medical supply distribution to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement through its extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies. The company holds significant standing within the Defense Logistics Agency's Medical Supply Chain, with demonstrated capability to deliver pharmaceuticals across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order for ZEJULA, an oncology medication, exemplifies the company's role in fulfilling specialized pharmaceutical needs for military and federal healthcare beneficiaries.
Quick answers
Who was awarded contract SPE2DB25FCZDZ?
SPE2DB25FCZDZ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 4, 2025.
How much is contract SPE2DB25FCZDZ worth?
The government has obligated $23,535 on SPE2DB25FCZDZ.
Is contract SPE2DB25FCZDZ an order under another contract?
Yes. SPE2DB25FCZDZ is a delivery order under SPE2DB24D1205, an indefinite delivery contract.
Was contract SPE2DB25FCZDZ competed?
The extent of competition for SPE2DB25FCZDZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award